Opioid Facilitation of β-Adrenergic Blockade: A New Pharmacological Condition?

Bibliographic Details
Title: Opioid Facilitation of β-Adrenergic Blockade: A New Pharmacological Condition?
Authors: Joseph Vamecq, Karine Mention-Mulliez, Francis Leclerc, Dries Dobbelaere
Source: Pharmaceuticals, Vol 8, Iss 4, Pp 664-674 (2015)
Publisher Information: MDPI AG, 2015.
Publication Year: 2015
Collection: LCC:Medicine
LCC:Pharmacy and materia medica
Subject Terms: lactate, glycolysis disruption, Na+/K+ ATPase, β-adrenergic receptor, G protein, cAMP, protein kinase A, shock, δ-opioid receptor, Medicine, Pharmacy and materia medica, RS1-441
More Details: Recently, propranolol was suggested to prevent hyperlactatemia in a child with hypovolemic shock through β-adrenergic blockade. Though it is a known inhibitor of glycolysis, propranolol, outside this observation, has never been reported to fully protect against lactate overproduction. On the other hand, literature evidence exists for a cross-talk between β-adrenergic receptors (protein targets of propranolol) and δ-opioid receptor. In this literature context, it is hypothesized here that anti-diarrheic racecadotril (a pro-drug of thiorphan, an inhibitor of enkephalinases), which, in the cited observation, was co-administered with propranolol, might have facilitated the β-blocker-driven inhibition of glycolysis and resulting lactate production. The opioid-facilitated β-adrenergic blockade would be essentially additivity or even synergism putatively existing between antagonism of β-adrenergic receptors and agonism of δ-opioid receptor in lowering cellular cAMP and dependent functions.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1424-8247
Relation: http://www.mdpi.com/1424-8247/8/4/664; https://doaj.org/toc/1424-8247
DOI: 10.3390/ph8040664
Access URL: https://doaj.org/article/e95a6400a45f4739913037a05d99ae7d
Accession Number: edsdoj.95a6400a45f4739913037a05d99ae7d
Database: Directory of Open Access Journals
More Details
ISSN:14248247
DOI:10.3390/ph8040664
Published in:Pharmaceuticals
Language:English